“MedGuide” Regulation Advocates Urge FDA To Take First Steps
Executive Summary
FDA and pharmacy groups should develop a priority list for mandatory medication guides as a first step towards regulation of consumer information leaflets for all prescriptions, advocates of a regulatory approach to "MedGuides" told an FDA public workshop July 31
You may also be interested in...
Mail Order Patient Leaflets Represent “Best Practices,” PCMA Tells FDA
Prescription drug leaflets distributed by mail-order pharmacies are of higher quality than the average retail leaflet, the Pharmaceutical Care Management Association maintains in comments submitted to FDA
Mail Order Patient Leaflets Represent “Best Practices,” PCMA Tells FDA
Prescription drug leaflets distributed by mail-order pharmacies are of higher quality than the average retail leaflet, the Pharmaceutical Care Management Association maintains in comments submitted to FDA
Rx “MedGuides” Will Meet 2006 Deadline For FDA Goals, First DataBank Says
First DataBank's consumer medical information leaflets are fully up-to-date with all black box warnings required by FDA, First DataBank Chief Operating Officer James Wilson declared during the National Association of Chain Drug Stores Pharmacy & Technology conference Aug. 25 in Philadelphia